At Crohn’s & Colitis Congress 2026, a large Mayo Clinic real-world analysis (580 GLP-1–exposed patients) found that patients with ulcerative…
Browsing: Clinical Updates
A recent analysis by healthcare innovation expert Jesse Pines, MD, examines whether the Galleri multi-cancer early detection (MCED) blood test…
A multicenter randomized trial in Japan shows that real-time peripheral gaze guidance significantly improves adenoma detection rate (ADR) during colonoscopy…
Basic science continued to advance gastroenterology and hepatology in 2025, offering new insights into disease mechanisms and revealing promising paths…
The U.S. FDA has approved Optune Pax, a first-of-its-kind wearable device from Novocure, for use in combination with gemcitabine and…
Pfizer reported up to 12.3% placebo-adjusted weight loss at 28 weeks in a phase 2b trial of PF-08653944 (formerly MET-097i),…
INTRODUCTION: The study aimed to develop consensus recommendations for the safe and appropriate use of liquid nitrogen spray cryotherapy in…
The U.S. FDA has granted Fast Track designation to pelareorep, an investigational immunotherapy from Oncolytics Biotech, in combination with bevacizumab…
Despite advances in outpatient therapies, hospitalization for adults with inflammatory bowel disease (IBD) remains common—and outcomes vary widely across institutions.…
The largest published study of molecular residual disease (MRD) in stage III colon cancer shows that Guardant Health’s ctDNA blood…